Dr. Zhou Ning graduated from Fudan University in 2010 with a doctorate degree in internal medicine. From 2013 to 2016, he was a postdoctoral scholar at the University of Chicago and Loma Linda. As the backbone of the Cardiac Critical Care Team of Tongji Hospital, Dr Zhou is committed to basic research on cardiac remodeling, myocardial metabolism and heart failure. In recent years, he has published more than 10 papers in authoritative SCI medical journals.

He presided over 2 projects of the National Natural Science Foundation of China, and has been involved as experts in project evaluation of the National Natural Science Foundation of China. Dr Zhou also won Top Ten Most Influential Young Cardiovascular Doctors in China in 2018, Winner of the 2018 China Cardiovascular Distinguished Contribution Award for Cardiovascular Medicine, 2017 Great Wall Youth Research Award Champion, Best Scientific Poster Award at the 2016 American College of Cardiology (ACC) Annual Conference and the best abstract of the Chinese papers, 2016 American Heart Association (AHA) Cardiovascular Disease Basic Forum (BCVS-ACRE) "Outstanding Young Scientist". Dr Zhou is the Member of North American Chinese Heart Association / American Heart Association, standing member of Youth Working Committee of Bethune Foundation, Secretary-General of Hubei Alliance of China Green Electrophysiology Alliance.

Expertise: diagnosis and treatment of cardiovascular diseases such as hypertension, coronary heart disease, arrhythmia and heart failure, especially electrocardiophysiology and cardiac pacing treatment, including various types of arrhythmia radiofrequency ablation (full three-dimensional), ICD / CRT / CRT -D implantation, pacemaker implantation, etc.

Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis Medical Center, Sacramento with Dr John Laird to complete his peripheral vascular interventional program. He is doubly accredited for cardiology and intensive care medicine in Singapore. He is the deputy head of cardiology and director of the coronary care unit at the National Heart Centre Singapore and the head of cardiology at Sengkang Hospital. He is a practising interventional cardiologist and holds adjunct assistant professor appointments at Duke NUS and lecturer appointment at the Yong Loo Lin Medical School. He was then selected for the executive MBA course and graduated in the Dean’s list for his cohort at the Singapore Management University. He is a faculty at regional and international meetings like TCT, EuroPCR and AsiaPCR and TCTAP. He is a frequent proctor for inteventional cardiology in countries like China, Cambodia, Vietnam, Philippines.

Dr Jack Tan successfully organized the ASEAN Federation of Cardiology Congress 2012 as the scientific chairman and was the organizing chairman for Asia Pacific Society of Cardiology meeting 2017. Currently he is an executive board member at Singapore Heart Foundation, APSIC (Asian Pacific Society of Interventional Cardiology) and ISCP(International Society of Cardiovascular Pharmacotherapy). He is the immediate past president of SCS (Singapore Cardiac Society) and immediate past board member (Continental chair) of WHF (World Heart Federation). He is the president-elect of ISCP and standing president of APSC (Asian Pacific Society of Cardiology).

Dr Ling is an Infectious Diseases Physician at the National Centre for Infectious Diseases(NCID) and Tan Tock Seng Hospital(TTSH), Singapore. She leads the ICU Multi-disciplinary Infectious Diseases and Haematology – Infectious Disease Programme at TTSH.
She is also interested in research on ICU infections, Candidaemia and beta lactam therapeutic drug monitoring.

Prof. Koji Hasegawa is currently the Director of the Division of Translational Research, National Hospital Organization Kyoto Medical Center. He is also the Visiting Professor, University of Shizuoka, Leader, Cardiovascular Clinical Research Network, National Hospital Organization (NHO), Executive Board of Director, President, Japan Cardiovascular Society (JCVA), Member of Tobacco Expert Group (TEG), World Heart Federation (WHF). His research interests include Prevention and Cardiovascular risk factor control, Smoking cessation, Pharmacotherapy, Heart failure, Biomarker, Molecular Cellular Biology.

Dr Ho is a consultant at the Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong. He is also the Cath Lab Director, at the hospital. He is a Council Member, Hong Kong Medical Association. He is also an Hon. Clinical Associate Professor at University of Hong Kong and Hon. Clinical Associate Professor, Chinese University of HK.
He is the Chief Editor for CME bulletin and Chairman for CME activities in Hong Kong Medical Association.
His most recent publication contribution is on the “Role of copeptin in dual-cardiac marker strategy for patients with chest pain presented to ED”, published in the American Journal of Emergency Medicine.
He has given more than 100 presentations on cases/abstracts/ lectures/ health talks for academic conferences as well as invited panelist and faculty in various international congresses.